About Novo Medi
Novo Medi is a Healthcare company based in Mumbai (India) founded in 1946 by Anju Gupta Kaudanya. It develops and manufactures vaccines for viral infections. It operates on a B2B model. The company has 262 employees. Its chief executive, as recorded, is Anju Gupta Kaudanya. Its Indian entity Novo Medi Sciences Private Limited reported revenue of ₹96.23 Cr. Its focus areas include Pharmaceuticals, Vaccine Development and Viral Vaccines.
Company details
Novo Medi, established in 1946, excels in providing healthcare solutions, producing pharmaceutical products, vaccine development, and viral vaccines. Develops and manufactures vaccines for viral infections. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
- Headquarters Mumbai, India
- Employees 262
- Founders Anju Gupta Kaudanya
- SectorsHealthcare
- Website novomedi.com
- Social X Facebook
- Legal Name Novo Medi Sciences Private Limited
- Date of Incorporation 29 Jun, 2013
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹96.23 Cr
FY 2023 · -3% YoY
- Net Profit₹52.9 Lakh
FY 2023 · 1% margin
- EBITDA₹10.19 Cr
FY 2023 · 11% margin
- Employee Count262
Associated legal entities of Novo Medi
Novo Medi operates through Novo Medi Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Novo Medi Sciences Private Limited CIN U33110MH2013PTC245027 | Active | 29 Jun 2013 | Mumbai, Maharashtra | ₹96.2 Cr | 262 | 4 | View details |
Board of directors of Novo Medi Sciences Private Limited (Novo Medi)
Novo Medi Sciences Private Limited is the primary company behind Novo Medi. The board of Novo Medi Sciences Private Limited currently have 4 directors; the longest-serving is Anju Sunil Kaudanya, appointed in 2013.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Anju Sunil Kaudanya DIN 01294050 | Director | 29 Jun 2013 | 13 yrs 4 mo | Novo Medi Sciences Private Limited |
| Vipulkumar Rameshchandra Bhagat DIN 01756677 | Director | 29 Jun 2013 | 13 yrs 4 mo | Novo Medi Sciences Private Limited |
| Forum Vipulkumar Bhagat DIN 07288677 | Director | 15 Sep 2015 | 11 yrs 1 mo | Novo Medi Sciences Private Limited |
| Karan Vipul Bhagat DIN 07288687 | Director | 30 Sep 2016 | 10 yrs 1 mo | Novo Medi Sciences Private Limited |
People of Novo Medi
1 people are tracked at Novo Medi (1 in leadership); the tracked headcount is 262.
| Name | Role | Group |
|---|---|---|
| Co-Founder, CEO | Leadership |
Complete people profiles for Novo Medi
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Novo Medi
Figures of Novo Medi Sciences Private Limited, the primary company behind Novo Medi, for FY 2023. Revenue was ₹96.23 Cr (-3% year on year). Net profit was ₹52.9 Lakh (1% margin). EBITDA was ₹10.19 Cr (11% margin). Revenue has grown at a compounded annual rate of +7% over three years and +16% over five years.
- ₹96.23 CrRevenue · FY 2023 · -3% YoY
- ₹52.9 LakhNet profit · 1% margin
- ₹10.19 CrEBITDA · 11% margin
- ₹19.70 CrPaid-up capital
- 262Employees (provident fund records)
- +7%Revenue CAGR, 3 years
- +16%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Novo Medi Sciences Private Limited are on its company page.
Detailed financial statements for Novo Medi
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Novo Medi
The website of Novo Medi (novomedi.com) receives about 9.2K visits a month.
- Monthly visits9.2K
▲ 53.6% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Novo Medi
Complete news archive for Novo Medi
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Novo Medi
Novo Medi was founded in 1946.
Novo Medi is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Anju Gupta Kaudanya is the CEO of Novo Medi, as recorded in our data. They have also founded this company.
Novo Medi has 262 employees.
The primary company behind Novo Medi, Novo Medi Sciences Private Limited, reported revenue of ₹96.23 Cr for FY 2023, down 3% year on year.
Novo Medi, established in 1946, excels in providing healthcare solutions, producing pharmaceutical products, vaccine development, and viral vaccines. Develops and manufactures vaccines for viral infections. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Novo Medi operates through Novo Medi Sciences Private Limited.
The legal entities of Novo Medi currently have 4 directors, including Anju Sunil Kaudanya, Vipulkumar Rameshchandra Bhagat, Forum Vipulkumar Bhagat and others.